{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:03:20Z","timestamp":1787061800955,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hydroxyethyl starch (HES) solutions are used for volume therapy to treat hypovolemia due to acute blood loss and to maintain hemodynamic stability. This study was requested by the European Medicines Agency (EMA) to provide more evidence on the long-term safety and efficacy of HES solutions in the perioperative setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PHOENICS is a randomized, controlled, double-blind, multi-center, multinational phase IV (IIIb) study with two parallel groups to investigate non-inferiority regarding the safety of a 6% HES 130 solution (Volulyte 6%, Fresenius Kabi, Germany) compared with a crystalloid solution (Ionolyte, Fresenius Kabi, Germany) for infusion in patients with acute blood loss during elective abdominal surgery. A total of 2280 eligible patients (male and female patients willing to participate, with expected blood loss \u2265 500 ml, aged &gt; 40 and \u2264 85 years, and ASA Physical status II\u2013III) are randomly assigned to receive either HES or crystalloid solution for the treatment of hypovolemia due to surgery-induced acute blood loss in hospitals in up to 11 European countries. The dosing of investigational products (IP) is individualized to patients\u2019 volume needs and guided by a volume algorithm. Patients are treated with IP for maximally 24 h or until the maximum daily dose of 30 ml\/kg body weight is reached.<\/jats:p>\n                    <jats:p>The primary endpoint is the treatment group mean difference in the change from the pre-operative baseline value in cystatin-C-based estimated glomerular filtration rate (eGFR), to the eGFR value calculated from the highest cystatin-C level measured during post-operative days 1-3. Further safety and efficacy parameters include, e.g., combined mortality\/major post-operative complications until day 90, renal function, coagulation, inflammation, hemodynamic variables, hospital length of stay, major post-operative complications, and 28-day, 90-day, and 1-year mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The study will provide important information on the long-term safety and efficacy of HES 130\/0.4 when administered according to the approved European product information. The results will be relevant for volume therapy of surgical patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      EudraCT\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2016-002162-30\/HR\/\">2016-002162-30<\/jats:ext-link>\n                      .\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03278548?term=NCT03278548&amp;draw=2&amp;rank=1\">NCT03278548<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-022-06058-6","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T05:03:08Z","timestamp":1645506188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prospective, randomized, controlled, double-blind, multi-center, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) sOlution versus an Electrolyte solutioN In patients undergoing eleCtive abdominal Surgery: study protocol for the PHOENICS study"],"prefix":"10.1186","volume":"23","author":[{"given":"Wolfgang","family":"Buhre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"de Korte-de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Gama","family":"de Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Scheeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Gruenewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hoeft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donat R.","family":"Spahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Daamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Brauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Dehnhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Schmier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"De Hert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017deljka","family":"Gavranovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cholley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Vymazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Szczeklik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmar","family":"Bornemann-Cimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Blanca","family":"Soro Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Grintescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radmilo","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Belda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"issue":"5","key":"6058_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/cc2851","volume":"8","author":"G Gutierrez","year":"2004","unstructured":"Gutierrez G, Reines HD, Wulf-Gutierrez ME. Clinical review: hemorrhagic shock. Critical Care. 2004;8(5):373\u201381. https:\/\/doi.org\/10.1186\/cc2851.","journal-title":"Critical Care."},{"issue":"2","key":"6058_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/ACO.0b013e328328d1b6","volume":"22","author":"D Chappell","year":"2009","unstructured":"Chappell D, Westphal M, Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Current Opinion in Anaesthesiology. 2009;22(2):155\u201362. https:\/\/doi.org\/10.1097\/ACO.0b013e328328d1b6.","journal-title":"Current Opinion in Anaesthesiology."},{"key":"6058_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10049-013-1805-8","volume":"16","author":"D Chappell","year":"2013","unstructured":"Chappell D, Jacob M. Fl\u00fcssigkeits- und Volumentherapie 2013 Fluid and volume therapy in 2013. Notfall + Rettungsmedizin. 2013;16:617\u201324.","journal-title":"Notfall + Rettungsmedizin"},{"issue":"07\/08","key":"6058_CR4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1055\/s-0032-1323570","volume":"47","author":"M Heringlake","year":"2012","unstructured":"Heringlake M, Heinze H, Brauer K. Perioperatives Fl\u00fcssigkeitsmanagement - Welches Volumen f\u00fcr welchen Patienten? Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie. 2012;47(07\/08):482\u20139. https:\/\/doi.org\/10.1055\/s-0032-1323570.","journal-title":"Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie."},{"issue":"2","key":"6058_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/bja\/aet307","volume":"112","author":"DRA Yates","year":"2014","unstructured":"Yates DRA, Davies SJ, Milner HE, Wilson RJT. Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery. British Journal of Anaesthesia. 2014;112(2):281\u20139. https:\/\/doi.org\/10.1093\/bja\/aet307.","journal-title":"British Journal of Anaesthesia."},{"key":"6058_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/ALN.0b013e31827e5569","volume":"118","author":"C Martin","year":"2013","unstructured":"Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130\/0.4 on renal function in surgical patients. Anesthesiology. 2013;118:387\u201394.","journal-title":"Anesthesiology"},{"issue":"2","key":"6058_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/CCM.0b013e3181feeb15","volume":"39","author":"JH Boyd","year":"2011","unstructured":"Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Critical Care Medicine. 2011;39(2):259\u201365. https:\/\/doi.org\/10.1097\/CCM.0b013e3181feeb15.","journal-title":"Critical Care Medicine."},{"issue":"4","key":"6058_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0885066613478899","volume":"29","author":"F Sadaka","year":"2014","unstructured":"Sadaka F, Juarez M, Naydenov S, O\u2019Brien J. Fluid resuscitation in septic shock: the effect of increasing fluid balance on mortality. J Intens Care Med. 2014;29(4):213\u20137. https:\/\/doi.org\/10.1177\/0885066613478899.","journal-title":"J Intens Care Med."},{"issue":"3","key":"6058_CR9","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/cc6916","volume":"12","author":"D Payen","year":"2008","unstructured":"Payen D, de Pont AC, Sakr Y, Spies C, Reinhart K, Vincent JL. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care. 2008;12(3):R74. https:\/\/doi.org\/10.1186\/cc6916.","journal-title":"Crit Care."},{"issue":"4","key":"6058_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/ki.2009.159","volume":"76","author":"J Bouchard","year":"2009","unstructured":"Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney International. 2009;76(4):422\u20137. https:\/\/doi.org\/10.1038\/ki.2009.159.","journal-title":"Kidney International."},{"issue":"1","key":"6058_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1213\/ANE.0b013e31827175da","volume":"116","author":"P Van Der Linden","year":"2013","unstructured":"Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesthesia and Analgesia. 2013;116(1):35\u201348. https:\/\/doi.org\/10.1213\/ANE.0b013e31827175da.","journal-title":"Anesthesia and Analgesia."},{"issue":"2","key":"6058_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1056\/NEJMoa1204242","volume":"367","author":"A Perner","year":"2012","unstructured":"Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, \u00c5neman A, et al. Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis. New England Journal of Medicine. 2012;367(2):124\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1204242.","journal-title":"New England Journal of Medicine."},{"issue":"20","key":"6058_CR13","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","volume":"367","author":"JA Myburgh","year":"2012","unstructured":"Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine. 2012;367(20):1901\u201311. https:\/\/doi.org\/10.1056\/NEJMoa1209759.","journal-title":"New England Journal of Medicine."},{"issue":"2","key":"6058_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa070716","volume":"358","author":"FM Brunkhorst","year":"2008","unstructured":"Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine. 2008;358(2):125\u201339. https:\/\/doi.org\/10.1056\/NEJMoa070716.","journal-title":"New England Journal of Medicine."},{"issue":"3","key":"6058_CR15","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1001\/jama.2019.20833","volume":"323","author":"E Futier","year":"2020","unstructured":"Futier E, Garot M, Godet T, Biais M, Verzilli D, Ouattara A, et al. Effect of hydroxyethyl starch vs saline for volume replacement therapy on death or postoperative complications among high-risk patients undergoing major abdominal surgery: the FLASH Randomized Clinical Trial. JAMA. 2020;323(3):1346\u201357. https:\/\/doi.org\/10.1001\/jama.2019.20833.","journal-title":"JAMA"},{"issue":"5","key":"6058_CR16","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/ALN.0000000000002601","volume":"130","author":"B Kabon","year":"2019","unstructured":"Kabon B, Sessler DI, Kurz A, Maheshwari K, Babazade R, Fiffick A, et al. Effect of intraoperative goal-directed balanced crystalloid versus colloid administration on major postoperative morbidity: a randomized trial. Anesthesiology. 2019;130(5):728\u201344. https:\/\/doi.org\/10.1097\/ALN.0000000000002601.","journal-title":"Anesthesiology."},{"issue":"1","key":"6058_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/ALN.0000000000001936","volume":"128","author":"A Joosten","year":"2018","unstructured":"Joosten A, Delaporte A, Ickx B, Touihri K, Stany I, Barvais L, et al. Crystalloid versus colloid for intraoperative goal-directed fluid therapy using a closed-loop system: a randomized, double-blinded, controlled trial in major abdominal surgery. Anesthesiology. 2018;128(1):55\u201366. https:\/\/doi.org\/10.1097\/ALN.0000000000001936.","journal-title":"Anesthesiology."},{"issue":"6","key":"6058_CR18","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jamcollsurg.2006.08.026","volume":"203","author":"FE Turrentine","year":"2006","unstructured":"Turrentine FE, Wang H, Simpson VB, Jones RS. Surgical risk factors, morbidity, and mortality in elderly patients. Journal of the American College of Surgeons. 2006;203(6):865\u201377. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2006.08.026.","journal-title":"Journal of the American College of Surgeons."},{"issue":"10","key":"6058_CR19","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/j.1365-2044.2010.06478.x","volume":"65","author":"DA Story","year":"2010","unstructured":"Story DA, Leslie K, Myles PS, Fink M, Poustie SJ, Forbes A, et al. Complications and mortality in older surgical patients in Australia and New Zealand (the REASON study): a multicentre, prospective, observational study. Anaesthesia. 2010;65(10):1022\u201330. https:\/\/doi.org\/10.1111\/j.1365-2044.2010.06478.x.","journal-title":"Anaesthesia."},{"issue":"6","key":"6058_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/EJA.0000000000000630","volume":"34","author":"SA Kozek-Langenecker","year":"2017","unstructured":"Kozek-Langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2017;34(6):270\u2013382. https:\/\/doi.org\/10.1097\/EJA.0000000000000630.","journal-title":"Eur J Anaesthesiol."},{"issue":"1","key":"6058_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. New England Journal of Medicine. 2012;367(1):20\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1114248.","journal-title":"New England Journal of Medicine."},{"issue":"3","key":"6058_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1590\/S0102-76382009000400008","volume":"24","author":"ML Felicio","year":"2009","unstructured":"Felicio ML, de Andrade RR, Castiglia YMM, Silva MA de M, Vianna PTG, Martins AS. Cystatin C and glomerular filtration rate in the cardiac surgery with cardiopulmonary bypass. Brazilian J Cardiovasc Surg. 2009;24(3):305\u201311. https:\/\/doi.org\/10.1590\/S0102-76382009000400008.","journal-title":"Brazilian J Cardiovasc Surg."},{"key":"6058_CR23","unstructured":"European Medicines Agency. ICH Topic E 9 Statistical Principles for Clinical Trials. London; 1998."},{"issue":"4","key":"6058_CR24","doi-asserted-by":"publisher","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"R Bellomo","year":"2004","unstructured":"Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204\u201312. https:\/\/doi.org\/10.1186\/cc2872.","journal-title":"Crit Care."},{"issue":"5","key":"6058_CR25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5603\/AIT.2014.0057","volume":"46","author":"S De Hert","year":"2014","unstructured":"De Hert S, De Baerdemaeker L. Why hydroxyethyl starch solutions should not be banned from the operating room. Anaesthesiology Intensive Therapy. 2014;46(5):336\u201341. https:\/\/doi.org\/10.5603\/AIT.2014.0057.","journal-title":"Anaesthesiology Intensive Therapy."},{"issue":"7","key":"6058_CR26","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/EJA.0000000000000447","volume":"33","author":"G Marx","year":"2016","unstructured":"Marx G, Schindler AW, Mosch C, Albers J, Bauer M, Gnass I, et al. Intravascular volume therapy in adults. European Journal of Anaesthesiology. 2016;33(7):488\u2013521. https:\/\/doi.org\/10.1097\/EJA.0000000000000447.","journal-title":"European Journal of Anaesthesiology."},{"issue":"21","key":"6058_CR27","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1001\/jama.2014.5305","volume":"311","author":"RM Pearse","year":"2014","unstructured":"Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, et al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery a randomized clinical trial and systematic review. JAMA. 2014;311(21):2181\u201390. https:\/\/doi.org\/10.1001\/jama.2014.5305.","journal-title":"JAMA"},{"issue":"7","key":"6058_CR28","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.2215\/CJN.00020110","volume":"5","author":"JP Van Kuijk","year":"2010","unstructured":"Van Kuijk JP, Flu WJ, Chonchol M, Hoeks SE, Winkel TA, Verhagen HJM, et al. Temporary perioperative decline of renal function is an independent predictor for chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(7):1198\u2013204. https:\/\/doi.org\/10.2215\/CJN.00020110.","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"6058_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jvs.2007.12.016","volume":"47","author":"GM Welten","year":"2008","unstructured":"Welten GM, Schouten O, Chonchol M. Temporary worsening of renal function after aortic surgery is associated with higher long-term mortality. J Vasc Surg. 2008;47(2):219\u201328. https:\/\/doi.org\/10.1016\/j.jvs.2007.12.016.","journal-title":"J Vasc Surg."},{"issue":"4","key":"6058_CR30","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/cc3057","volume":"9","author":"O Boyd","year":"2005","unstructured":"Boyd O, Jackson N. Clinical review: how is risk defined in high-risk surgical patient management? Crit Care. 2005;9(4):390\u20136. https:\/\/doi.org\/10.1186\/cc3057.","journal-title":"Crit Care."},{"issue":"6","key":"6058_CR31","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1213\/ANE.0b013e3181eeaae5","volume":"112","author":"MA Hamilton","year":"2011","unstructured":"Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesthesia and Analgesia. 2011;112(6):1392\u2013402. https:\/\/doi.org\/10.1213\/ANE.0b013e3181eeaae5.","journal-title":"Anesthesia and Analgesia."},{"issue":"3","key":"6058_CR32","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/01.sla.0000179621.33268.83","volume":"242","author":"SF Khuri","year":"2005","unstructured":"Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242(3):326\u201341. https:\/\/doi.org\/10.1097\/01.sla.0000179621.33268.83.","journal-title":"Ann Surg."},{"issue":"oct02 2","key":"6058_CR33","doi-asserted-by":"publisher","first-page":"a1469","DOI":"10.1136\/bmj.a1469","volume":"337","author":"J Head","year":"2008","unstructured":"Head J, Ferrie JE, Alexanderson K, Westerlund H, Vahtera J, Kivim\u00e4ki M. Diagnosis-specific sickness absence as a predictor of mortality: the Whitehall II prospective cohort study. BMJ. 2008;337(oct02 2):a1469. https:\/\/doi.org\/10.1136\/bmj.a1469.","journal-title":"BMJ."},{"issue":"1","key":"6058_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2047-0525-1-6","volume":"1","author":"S Calvert","year":"2012","unstructured":"Calvert S, Shaw A. Perioperative acute kidney injury. Perioperative Medicine. 2012;1(1):6. https:\/\/doi.org\/10.1186\/2047-0525-1-6.","journal-title":"Perioperative Medicine."},{"issue":"6","key":"6058_CR35","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/01.anes.0000290588.29668.38","volume":"107","author":"S Kheterpal","year":"2007","unstructured":"Kheterpal S, Tremper KK, Englesbe MJ, O\u2019Reilly M, Shanks AM, Fetterman DM, et al. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology. 2007;107(6):892\u2013902. https:\/\/doi.org\/10.1097\/01.anes.0000290588.29668.38.","journal-title":"Anesthesiology."},{"issue":"6","key":"6058_CR36","doi-asserted-by":"publisher","first-page":"R288","DOI":"10.1186\/cc13151","volume":"17","author":"JM Silva","year":"2013","unstructured":"Silva JM, De Oliveira AMRR, Nogueira FAM, Vianna PMM, Pereira Filho MC, Dias LF, et al. The effect of excess fluid balance on the mortality rate of surgical patients: a multicenter prospective study. Crit Care. 2013;17(6):R288. https:\/\/doi.org\/10.1186\/cc13151.","journal-title":"Crit Care."},{"issue":"3","key":"6058_CR37","doi-asserted-by":"publisher","first-page":"R81","DOI":"10.1186\/cc4928","volume":"10","author":"RM Pearse","year":"2006","unstructured":"Pearse RM, Harrison DA, James P, Watson D, Hinds C, Rhodes A, et al. Identification and characterisation of the high-risk surgical population in the United Kingdom. Critical Care. 2006;10(3):R81. https:\/\/doi.org\/10.1186\/cc4928.","journal-title":"Critical Care."},{"issue":"9847","key":"6058_CR38","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(12)61148-9","volume":"380","author":"RM Pearse","year":"2012","unstructured":"Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, et al. Mortality after surgery in Europe: a 7 day cohort study. The Lancet. 2012;380(9847):1059\u201365. https:\/\/doi.org\/10.1016\/S0140-6736(12)61148-9.","journal-title":"The Lancet."},{"issue":"4","key":"6058_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00134-015-4157-7","volume":"42","author":"ME O\u2019Connor","year":"2016","unstructured":"O\u2019Connor ME, Kirwan CJ, Pearse RM, Prowle JR. Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Medicine. 2016;42(4):521\u201330. https:\/\/doi.org\/10.1007\/s00134-015-4157-7.","journal-title":"Intensive Care Medicine."},{"issue":"1","key":"6058_CR40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/bja\/aei018","volume":"95","author":"JW Sear","year":"2005","unstructured":"Sear JW. Kidney dysfunction in the postoperative period. British Journal of Anaesthesia. 2005;95(1):20\u201332. https:\/\/doi.org\/10.1093\/bja\/aei018.","journal-title":"British Journal of Anaesthesia."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06058-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06058-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06058-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T05:11:46Z","timestamp":1645506706000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06058-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6058"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06058-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"21 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Medizinische Ethikkommission der Carl von Ossietzky Universit\u00e4t Oldenburg, reference number 2017-008. Written, informed consent to participate will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Wolfgang Buhre is a member of the Steering Committee of the Prodigy Study (sponsored by Medtronic), POSE Study (supported by ESAIC), Designation Study (supported with a grant from ZonMw), and PI of the AMAZONE study (supported with grants from the Dutch Cancer Society and ESAIC). Ute Brauer, Tamara Dehnhardt, and Sonja Schmier are employees of B. Braun Melsungen AG. Martin Westphal is and Jean-Francois Baron was an employee of Fresenius Kabi. Thomas Scheeren received research grants and honoraria from Edwards Lifesciences (Irvine, CA, USA) and Masimo Inc. (Irvine, CA, USA) for consulting and lecturing and from Pulsion Medical Systems SE (Feldkirchen, Germany) for lecturing (all payments made to the institution). Matthias Grunewald has received honoraria from CSL Behring, GE Healthcare, Gruenenthal, and Vifor Pharma (all unrelated to the PHOENICS study). Donald Spahn\u2019s department is receiving grant support from Swiss National Science Foundation, the Swiss Society of Anesthesiology and Reanimation (SGAR), the Swiss Foundation for Anesthesia Research, Vifor SA, and Vifor (International) AG, Switzerland. Dr. Spahn is co-chair of the ABC-Trauma Faculty, sponsored by unrestricted educational grants from Novo Nordisk Health Care AG, Zurich, Switzerland; CSL Behring GmbH, Marburg, Germany; LFB Biom\u00e9dicaments, Courtaboeuf Cedex, France; and Octapharma AG, Lachen, Switzerland. Dr. Spahn received honoraria\/travel support for consulting or lecturing from Danube University of Krems, Austria; US Department of Defense, Washington, USA; European Society of Anesthesiology, Brussels, BE; Korean Society for Patient Blood Management, Seoul, Korea; Korean Society of Anesthesiologists, Seoul, Korea; Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis, Paris, France; Baxalta Switzerland AG, Volketswil, Switzerland; Bayer AG, Z\u00fcrich, Switzerland; B. Braun Melsungen AG, Melsungen, Germany; Boehringer Ingelheim GmbH, Basel, Switzerland; Bristol-Myers-Squibb, Rueil-Malmaison Cedex, France and Baar, Switzerland; CSL Behring GmbH, Hattersheim am Main, Germany, and Berne, Switzerland; Celgene International II S\u00e0rl, Couvet, Switzerland; Daiichi Sankyo AG, Thalwil, Switzerland; Haemonetics, Braintree, MA, USA; Instrumentation Laboratory (Werfen), Bedford, MA, USA; LFB Biom\u00e9dicaments, Courtaboeuf Cedex, France; Merck Sharp & Dohme, Kenilworth, NJ, USA; PAION Deutschland GmbH, Aachen, Germany; Pharmacosmos A\/S, Holbaek, Denmark; Pfizer AG, Z\u00fcrich, Switzerland; Pierre Fabre Pharma, Alschwil, Switzerland, Portola Schweiz GmbH, Aarau, Switzerland; Roche Diagnostics International Ltd., Reinach, Switzerland; Sarstedt AG & Co., Sevelen, Switzerland and N\u00fcmbrecht, Germany; Shire Switzerland GmbH, Zug, Switzerland; Tem International GmbH, Munich, Germany; Vifor Pharma, Munich, Germany; Neuilly sur Seine, France and Villars-sur-Gl\u00e2ne, Switzerland; Vifor (International) AG, St. Gallen, Switzerland; and Zuellig Pharma Holdings, Singapore, Singapore. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}